Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
AZ pauses $271M UK expansion as British backtrack continues
The investment was meant to fund a facility near AstraZeneca’s Cambridge headquarters that would have employed around 1,000 people.
Darren Incorvaia
Sep 12, 2025 2:44pm
Eli Lilly reconsiders UK biotech incubator
Sep 12, 2025 12:09pm
Fierce Pharma
Under Trump, FDA seeks to abandon expert reviews of new drugs
Sep 12, 2025 9:50am
Neurescue nets European approval in non-shockable cardiac arrest
Sep 12, 2025 2:00pm
Philips, Masimo re-up patient monitor partnership with AI focus
Sep 12, 2025 12:00pm
Galimedix’s oral Alzheimer’s candidate clears ph. 1 safety test
Sep 12, 2025 11:11am
More News
Takeda taps longtime Lilly exec as US head—Chutes & Ladders
Sep 12, 2025 8:30am
Fierce Pharma
Nominations open for Fiercest Women in Life Sciences 2025
Sep 12, 2025 7:00am
Fierce Pharma
Novo Nordisk tells employees they must return to office Jan. 1
Sep 11, 2025 2:13pm
Custom gene editor fixes mutation causing deadly disease in mice
Sep 11, 2025 1:48pm
See more stories